Relation of smoking and endothelial dysfunction markers in systemic hypertension

Relation of smoking and endothelial dysfunction markers in systemic hypertension

Aim. Assessment of the markers levels of endothelial dysfunction (ED): stable metabolites of nitric oxide (NOx), endothelin-1 (E1), homocysteine (HC), von Willebrand factor (vWF) and tissue plasminogen activator (tPA) in blood plasma of smoker and nonsmoker patients with arterial hypertension (AH) o...

Full description

Saved in:

Bibliographic Details
Main Authors:	V. I. Podzolkov, A. E. Bragina, N. A. Druzhinina
Format:	Article
Language:	Russian
Published:	«SILICEA-POLIGRAF» LLC 2018-10-01
Series:	Кардиоваскулярная терапия и профилактика
Subjects:	arterial hypertension smoking nitric oxide von willebrand factor homocysteine endothelial dysfunction
Online Access:	https://cardiovascular.elpub.ru/jour/article/view/772
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

PROGNOSTIC SIGNIFICANCE OF ENDOTHELIAL DYSFUNCTION MARKERS IN ARTERIAL HYPERTENSION
by: V. I. Podzolkov, et al.
Published: (2018-05-01)

THE INVOLVEMENT OF ENDOTHELIAL DYSFUNCTION MARKERS IN THE PATHOGENESIS OF CHRONIC GLOMERULONEPHRITIS
by: T.V. Margieva, et al.
Published: (2006-03-01)

THE STATE OF NITROXIDE PRODUCTION FUNCTION OF ENDOTHELIUM AND LEFT VENTRICLE HYPERTROPHY IN ARTERIAL HYPERTENSION
by: V. I. Podzolkov, et al.
Published: (2017-08-01)

Endothelial Dysfunction Markers in Ovarian Cancer: VTE Risk and Tumour Prognostic Outcomes
by: Inês Guerra de Melo, et al.
Published: (2024-12-01)

Comparison of endothelial function in patients with Stage I-II arterial hypertension and stable angina, receiving various bradycardic agents and perindopril
by: L. L. Kirichenko, et al.
Published: (1970-01-01)

Features of coronary heart disease in a cohort of tajik patients and the condition of the vascular endothelium in its different clinical forms
by: F. A. Shukurov, et al.
Published: (2024-06-01)

Study of the state of th vascular endothelium in various forms of coronary heart disease
by: F. A. Shukurov, et al.
Published: (2023-09-01)

Vascular markers of cognitive dysfunction in patients with uncontrolled arterial hypertension
by: V. I. Podzolkov, et al.
Published: (2020-11-01)

Endothelial Dysfunction in Trauma: Pathogenesis, Clinical Significance, Diagnosis and Treatment
by: V. V. Matyukhin, et al.
Published: (2025-01-01)

Risk of endothelial dysfunction in streptozotocin-induced diabetic Sprague-Dawley rats: Nitric oxide in focus
by: M.L. Jidda J.M. Bunza M.K. Dallatu L.S. Bilbis A.J. Alhassan Muhammad Yelwa Gwarzo A.A. Ngaski A.F. Chiroma S.L. Kakako Maryam Kasimu B.M. Yale M. Kasimu S. Haruna K.A. Ogunwale A. K. Bello Ibrahim Kalle Kwaifa
Published: (2023-09-01)

Endothelial dysfunction in patients with various forms of congenital epidermolysis bullosa
by: V. I. Kornev, et al.
Published: (2022-11-01)

Relationship of Circulating Endothelial Cells, Endothelial Progenitor Cells, and Endothelial Dysfunction after High-Intensity Exercise: Role of Nitric Oxide
by: Rias Gesang Kinanti, et al.
Published: (2023-06-01)

Markers of Endothelial Dysfunction: E-selectin, Endothelin-1 and von Willebrand Factor in Patients with Coronary Heart Disease, Including in Combination with Type 2 Diabetes Mellitus
by: A. V. Zhito, et al.
Published: (2020-01-01)

Arterial hypertension therapy effectiveness in smokers
by: D. V. Nebieridze, et al.
Published: (2007-02-01)

Vascular-type heterogeneity is associated with differential gene expression profiles of endothelial cells under shear stress
by: Allaura A. Cox, et al.
Published: (2025-05-01)

Association of nitric oxide levels and lipid profile with endothelial dysfunction in type 2 diabetic patients
by: Hamza Algomizy, et al.
Published: (2024-10-01)

The functional state of endothelium at chronic hepatitis C
by: I. A. Bulatova, et al.
Published: (2009-06-01)

Dynamics of endothelial function violation in patients with arterial hypertension with moderate cardiovascular risk and antihypertensive therapy treatment influence
by: T. S. Turlyun
Published: (2016-08-01)

Nitric oxide role and endothelial dysfunction development in diabetes mellitus
by: S. G. Dzugkoev, et al.
Published: (1970-01-01)

Endothelial dysfunction and apoptosis in the pathogenesis of cognitive impairment in patients with arterial hypertension
by: M. V. Ivanov, et al.
Published: (2009-02-01)

EFFECT OF FUROSTANOL GLYCOSIDES FROM CULTURED DIOSCOREA DELTOIDEA CELLS ON REGULATORY FUNCTION OF ENDOTHELIUM IN A RAT MODEL OF HYPOESTROGEN-INDUCED ENDOTHELIAL DYSFUNCTION
by: E. B. Artyushkova, et al.
Published: (2016-01-01)

Influence of von Willebrand factor on common pathophysiological mechanisms of cerebrovascular diseases and multiple sclerosis
by: I. A. Koltsov, et al.
Published: (2021-09-01)

ACE INHIBITORS ARE RATIONAL PHARMACOTHERAPY OF ENDOTHELIAL DYSFUNCTION
by: M. P. Metrova, et al.
Published: (2016-01-01)

ACTIVITY MODULATION OF VARIOUS NITRIC OXIDE SYNTASES AS AN APPROACH TO ENDOTHELIAL DYSFUNCTION THERAPY
by: D. V. Kurkin, et al.
Published: (2022-05-01)

Metabolic syndrome as a clinical manifestation of endothelial dysfunction
by: L. L. Kirichenko, et al.
Published: (2012-04-01)

Endothelial dysfuncton and 2 type diabetes: novel markers for earlier diagnostics
by: I. A. Khripun, et al.
Published: (2016-10-01)

Dynamics of laboratory markers of endothelial dysfunction in patients with psoriatic arthritis under the influence of the interleukin-17A inhibitor netakimab
by: A. V. Petrov, et al.
Published: (2024-12-01)

Arterial hypertension as a consequence of endothelial glycocalyx dysfunction: a modern view of the problem of cardiovascular diseases
by: M. M. Ziganshina, et al.
Published: (2022-10-01)

Evaluation of Plasma Nitric Oxide and Serum Endothelial Nitric Oxide Synthase in Pulmonary Hypertensive Dogs: A Clinical and Echocardiography Investigation
by: Siwayu Rattanakanokchai, et al.
Published: (2025-05-01)

Endothelial dysfunction in hypertension: cause or effect?
by: A. Yu. Gorshkov, et al.
Published: (2019-12-01)

Endothelial Dysfunction, Functional Structural Changes in the Vessels in Patients with the Unstable Angina with Arterial Hypertension
by: Denesiuk O.
Published: (2013-03-01)

Role of homocysteine metabolism in the development of endothelial dysfunction and hypertension in patients with multiple myeloma
by: I. L. Davydkin, et al.
Published: (2022-02-01)

Nitric oxide role in development of the endothelial dysfunction in diabetic foot syndrome
by: O. O. Bilyayeva, et al.
Published: (2019-12-01)

EFFICACY AND SAFETY OF FIXED COMBINATION OF LISINOPRIL AND HYDROCHLOROTHIAZIDE FOR MANAGEMENT OF VASCULAR DISORDERS IN PATIENTS WITH ARTERIAL HYPERTENSION
by: L. A. Haisheva
Published: (2016-01-01)

ENDOTHELIAL FUNCTION CHANGES IN PRE- AND POST-MENOPAUSAL WOMEN WITH ARTERIAL HYPERTENSION
by: E. B. Prokofyeva, et al.
Published: (2012-12-01)

Endothelial function in young men with essential hypertension
by: G. R. Yanovskaya, et al.
Published: (2004-06-01)

Endothelial dysfunction markers in young patients with silent arterial hypertension
by: S. D. Mayanskaya, et al.
Published: (2004-12-01)

Advances in Research on the Release of von Willebrand Factor from Endothelial Cells through the Membrane Attack Complex C5b-9 in Sepsis
by: Liu Y, et al.
Published: (2025-05-01)

von Willebrand Factor (VWF) Inhibitors in Two Brothers with von Willebrand Disease: A Case Report
by: Claudia Djambas Khayat, et al.
Published: (2025-01-01)

Hemodynamic activation of von Willebrand factor in children with congenital heart diseases
by: K. A. Tokmakova, et al.
Published: (2024-11-01)